Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Solid Tumours 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Long QT Syndrome 1Hot Flashes 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Moxifloxacin 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Long QT Syndrome × Moxifloxacin × Clear all
NCT03258515 2020-02-20

A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

AstraZeneca

Phase 1 Completed
45 enrolled

Long QT Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡